MARIA RODRIGUEZ-BARRADAS to Streptococcus pneumoniae
This is a "connection" page, showing publications MARIA RODRIGUEZ-BARRADAS has written about Streptococcus pneumoniae.
Connection Strength
0.665
-
Colonization by Streptococcus pneumoniae among human immunodeficiency virus-infected adults: prevalence of antibiotic resistance, impact of immunization, and characterization by polymerase chain reaction with BOX primers of isolates from persistent S. pneumoniae carriers. J Infect Dis. 1997 Mar; 175(3):590-7.
Score: 0.117
-
Protease Inhibitors Do Not Affect Antibody Responses to Pneumococcal Vaccination. Clin Vaccine Immunol. 2016 06; 23(6):524-529.
Score: 0.111
-
IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. J Infect Dis. 1996 Jun; 173(6):1347-53.
Score: 0.111
-
Quantitative and Qualitative Antibody Responses to Immunization With the Pneumococcal Polysaccharide Vaccine in HIV-Infected Patients After Initiation of Antiretroviral Treatment: Results From a Randomized Clinical Trial. J Infect Dis. 2015 Jun 01; 211(11):1703-11.
Score: 0.101
-
Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis. 1992 Mar; 165(3):553-6.
Score: 0.083
-
IgG responses to protein-conjugated pneumococcal capsular polysaccharides in persons who are genetically incapable of responding to unconjugated polysaccharides. Clin Infect Dis. 1998 Dec; 27(6):1487-90.
Score: 0.033
-
Human antibodies elicited by a pneumococcal vaccine express idiotypic determinants indicative of V(H)3 gene segment usage. J Infect Dis. 1998 Sep; 178(3):707-16.
Score: 0.033
-
BOX-polymerase chain reaction-based DNA analysis of nonserotypeable Streptococcus pneumoniae implicated in outbreaks of conjunctivitis. J Infect Dis. 1997 Nov; 176(5):1401-5.
Score: 0.031
-
Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J Infect Dis. 1996 Jan; 173(1):83-90.
Score: 0.027
-
Qualitative change in antibody responses of human immunodeficiency virus-infected individuals to pneumococcal capsular polysaccharide vaccination associated with highly active antiretroviral therapy. J Infect Dis. 2003 Mar 01; 187(5):758-68.
Score: 0.011
-
Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis. 1996 Jan; 22(1):100-6.
Score: 0.007